Copyright
©The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Jun 14, 2016; 22(22): 5267-5275
Published online Jun 14, 2016. doi: 10.3748/wjg.v22.i22.5267
Published online Jun 14, 2016. doi: 10.3748/wjg.v22.i22.5267
Inflammatory bowel disease: A descriptive study of 716 local Chilean patients
Daniela Simian, Academic Research Unit, Clínica Las Condes, Santiago 7591046, Chile
Daniela Fluxá, Gastroenterology Departament, Clínica Las Condes, Santiago 7591046, Chile
Lilian Flores, Jaime Lubascher, Patricio Ibáñez, Carolina Figueroa, Raúl Acuña, Rodrigo Quera, Inflammatory Bowel Disease Program, Gastroenterology Department, Clínica Las Condes, Santiago 7591046, Chile
Udo Kronberg, Inflammatory Bowel Disease Program, Colorectal Surgery Department, Clínica Las Condes, Santiago 7591046, Chile
Mauricio Moreno, Laboratory of Oncology and Molecular Genetics, Colorectal Surgery, Clínica Las Condes, Santiago 7591046, Chile
Author contributions: Simian D, Flores L, Kronberg U and Quera R designed the research; Simian D, Flores L, Quera R, Ibáñez P, Lubascher J, Figueroa C and Kronberg U performed the research; Simian D, Flores L, Lubascher J, Ibáñez P, Figueroa C, Kronberg U, Acuña R and Quera R contributed new reagents/analytic tools; Simian D, Fluxá D, Flores L and Moreno M analyzed the data; Simian D, Fluxá D and Quera R wrote the paper.
Institutional review board statement: The study was approved by the institutional Ethics Committee.
Informed consent statement: All study participants provided verbal consent prior to inclusion in the study; the identity of the subjects under study was anonymized.
Conflict-of-interest statement: There are no conflicts in interest to report.
Data sharing statement: No additional data available.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Rodrigo Quera, MD, Inflammatory Bowel Disease Program, Gastroenterology Department, Clínica Las Condes, Lo Fontecilla 441, Las Condes, Santiago 7591046, Chile. rquera@clc.cl
Telephone: +56-2-26108048 Fax: +56-2-26208719
Received: February 18, 2016
Peer-review started: February 21, 2016
First decision: March 21, 2016
Revised: April 9, 2016
Accepted: May 4, 2016
Article in press: May 4, 2016
Published online: June 14, 2016
Processing time: 104 Days and 17 Hours
Peer-review started: February 21, 2016
First decision: March 21, 2016
Revised: April 9, 2016
Accepted: May 4, 2016
Article in press: May 4, 2016
Published online: June 14, 2016
Processing time: 104 Days and 17 Hours
Core Tip
Core tip: Several studies have found that the incidence of inflammatory bowel disease (IBD) has increased over the past several decades, even in countries where the frequency was extremely low. Industrialization, increased physician awareness, advancements in diagnostic methods and better access to medical services are factors that might explain this increase. Although few epidemiological studies have been conducted in Latin America, these analyses have described an increased incidence of IBD. In the present study, we analyzed single-center data of 716 patients with IBD. We collected data from a considerable number of patients diagnosed with IBD, enabling the demographic and clinical characterization of these individuals.